Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: Regulation by fatty acids and glucose

Islets

Volumn 2, Issue 3, 2010, Pages

  Hyder, Ayman ^a   Zenhom, Marwa ^a   Klapper, Maja ^a   Herrmann, Julia ^a   Schrezenmeir, Jürgen ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

FABP; Fatty acids; Gene expression; INS 1E cells; Insulin secretion; Rat islets

Indexed keywords

BETA ACTIN; CYCLOHEXIMIDE; ETOMOXIR; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 3; FATTY ACID BINDING PROTEIN 5; GLUCOSAMINE; GLUCOSE; INSULIN; LINOLEIC ACID; LINOLENIC ACID; MESSENGER RNA; METFORMIN; OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; UNCLASSIFIED DRUG; EYE PROTEIN; FABP3 PROTEIN, RAT; FABP5 PROTEIN, RAT; FATTY ACID; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; EPIDERMIS CELL; FATTY ACID OXIDATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; INSULIN RELEASE; INSULINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PROTEIN SYNTHESIS; RAT; TUMOR CELL LINE; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PANCREAS ISLET; PHYSIOLOGY; SECRETION;

ANIMALS; CELL LINE, TUMOR; EYE PROTEINS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; GENE EXPRESSION REGULATION; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LIPID METABOLISM; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS;

EID: 85046916228     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.2.3.11454     Document Type: Article

References (51)

1. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. PNAS 1994; 91:10878-10882
2. Zhou YP, Grill V. Long-term exposure to fatty acids and ketones inhibits beta-cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab 1995; 80:1584-1590
3. Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 2002; 51:1437-1442
4. Zhou YP, Berggren PO, Grill V. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes 1996; 45:580-586
5. Ayvaz G, Balos Toruner F, Karakoc A, Yetkin I, Cakir N, Arslan M. Acute and chronic effects of different concentrations of free fatty acids on the insulin secreting function of islets. Diabetes Metab 2002; 28:7-12.
6. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1990; 127:1580-1589 (Pubitemid 20315212)
7. Paolisso G, Tagliamonte MR, Rizzo MR, Gualdiero P, Saccomanno G, Gambardella A, et al. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type 2 diabetes. Diabetologia 1998; 41:1127-1132 (Pubitemid 28449076)
8. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF. Acute enhancement of insulin secretion by FAs in humans is lost with prolonged FAs elevation. Am J Physiol 1999; 276:1055-1066
9. El-assaad W, Buteau J, Peyot M, Nolan C, Roduit R, Hardy S, et al. Saturated Fatty acids synergize with elevated glucose to cause pancreatic β-cell death. Endocrinology 2003; 144:4154-4163
10. Poitout V, Hagman D, Stein R, Artner I, Robertson R, Harmon J. Regulation of the Insulin Gene by Glucose and Fatty Acids. J Nutr 2006; 136:873-876
11. Briaud I, Harmon JS, Kelpe CL, Segu VB, Poitout V. Lipotoxicity of the pancreatic β-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 2001; 50:315-321
12. Jensen CB, Storgaard H, Holst JJ, Dela F, Madsbad S, Vaag AA. Insulin secretion and cellular glucose metabolism after prolonged low-grade Intralipid infusion in young men. J Clin Endocrinol Metab 2003; 88:2775-2783
13. Gravena C, Mathias PC, Ashcroft SJ. Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans. J Endocrinol 2002; 173:73-80. (Pubitemid 34428893)
14. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 2003; 52:726-733 (Pubitemid 36323580)
15. Alstrup K, Brock B, Hermansen K. Long-term exposure of INS-1 cells to cis and trans fatty acids influences insulin release and fatty acid oxidation differentially. Metabolism 2004; 53:1158-1165 (Pubitemid 39140751)
16. Noushmehr H, D'Amico E, Farilla L, Hui H, Wawrowsky KA, Mlynarski W, et al. Fatty acid translocase (FAT/CD36) is localized on insulin-containing granules in human pancreatic β-cells and mediates fatty acid effects on Insulin secretion. Diabetes 2005; 54:472-481
17. Veerkamp JH, van Moerkerk HT, Prinsen CF, van Kuppevelt TH. Structural and functional studies on different human FABP types. Mol Cel Bioch 1999; 192:137-142
18. Schroeder F, Petrescu A, Huang H, Atshaves BP, McIntosh AL, Martin GG, et al. Role of Fatty Acid Binding Proteins and Long Chain Fatty Acids in Modulating Nuclear Receptors and Gene Transcription. Lipids 2008; 43:1-17. (Pubitemid 351206956)
19. Khan SH, Sorof S. Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. PNAS 1994; 91:848-852 (Pubitemid 24048464)
20. Wang HL, Kurtz A. Breast cancer growth inhibition by delivery of the MDGI-derived peptide P108. Oncogene 2000; 19:2455-2460 (Pubitemid 30323479)
21. Bennaars-Eiden A, Higgins L, Hertzel AV, Kapphahn RJ, Ferrington DA, Bernlohr DA. Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo - evidence for a role in antioxidant biology. J Biol Chem 2002; 277:50693-50702 (Pubitemid 36042231)
22. Odani S, Namba Y, Ishii A, Ono T, Fujii H. Disulfide bonds in rat cutaneous fatty acid-binding protein. J Biochem 2000; 128:355-361
23. Hegele RA. A review of intestinal fatty acid binding protein gene variation and the plasma lipoprotein response to dietary components. Clin Biochem 1998; 31:609-612
24. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 2004; 145:667-678 (Pubitemid 38183809)
25. Hyder A, Laue C, Schrezenmeir J. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of 2 different species and age categories. Toxicol In Vitro 2005; 19:541-546 (Pubitemid 40501720)
26. Welters H, Smith S, Tadayyon M, Scarpello J, Morgan N. Evidence that protein kinase Cδ is not required for palmitate-induced cytotoxicity in BRIN-BD11 β-cells. J Mol Endocrinol 2004; 32:227-235 (Pubitemid 38312633)
27. Watanabe M, Ono T, Kondo H. Immunohistochemical studies on the localisation and ontogeny of heart fatty acid binding protein in the rat. J Anat 1991; 174:81-95.
28. 2+ currents and the size and readily releasable granule pool in mouse pancreatic beta-cells. J Physiol 2004; 557:935-948
29. Zhou YT, Shimabukuro M, Wang MY, Lee Y, Higa M, Milburn JL, et al. Role of peroxisome proliferatoractivated receptor α in disease of pancreatic b cells. PNAS 1998; 95:8898-8903 (Pubitemid 28350586)
30. Prentki M, Tornheim K, Corkey B. Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 1997; 40:32-41.
31. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108:1167-1174 (Pubitemid 32995375)
32. Shaw R, Lamia K, Vasquez D, Koo S, Bardeesy N, Depinho R, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005; 310:1642-1646 (Pubitemid 41780780)
33. Hardie DG, Pan DA. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 2001; 30:1064-1070
34. Carey JO, Neufer PD, Farrar RP, Veerkamp JH, Dohm GL. Transcriptional regulation of muscle fatty acid-binding protein. Biochem J 1994; 298:613-617 (Pubitemid 24085185)
35. Meunier-Durmort C, Poirier H, Niot I, Forest C, Besnard P. Upregulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids. Biochem J 1996; 319:483-487 (Pubitemid 26372207)
36. Mallordy A, Poirier H, Besnard P, Niot I, Carlier H. Evidence for transcriptional induction of the liver fatty-acid-binding-protein gene by bezafibrate in the small intestine. Eur J Biochem 1995; 227:801-807
37. Poirier H, Niot I, Degrace P, Monnot MC, Bernard A, Besnard P. Fatty acid regulation of fatty acid-binding protein expression in the small intestine. Am J Physiol 1997; 273:289-295
38. Prentki M, Vischer S, Glennon M, Regazzi R, Deeney J, Corkey B. Malonyl-CoA and long-chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 1992; 267:5802-5810
39. Prentki M, Corkey B. Are the β-cell signalling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 1996; 45:273-283
40. Roduit R, Morin J, Masse F, Segall L, Roche E, Newgard C, et al. Glucose downregulates the expression of the peroxisome proliferator-activated receptor-alpha in the pancreatic β-cell. J Biol Chem 2000; 275:35799-35806
41. Laybutt D, Sharma A, Sgroi D, Gaudet J, Bonner-Weir S, Weir G. Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem 2002; 277:10912-10921
42. Auwerx J. PPAR, the ultimate thrifty gene. Diabetologia 1999; 42:1033-1049
43. Schachtrup C, Emmler T, Bleck B, Sandqvist A, spener F. Functional analysis of peroxisome proliferator response element motifs in genes of fatty acid binding proteins. Biochem J 2004; 382:239-245
44. Holst D, Luquest S, Nogueira V, Kristiansen K, Leverve X, Grimaldi P. Nutritional egulation and role of peroxisome proliferator-activated receptor d in fatty acid catabolism in skeletal muscle. Biochem Biophys Acta 2003; 1633:43-50. (Pubitemid 36773945)
45. Tan N, Shaw N, Vinckenbosch N, Liu P, Yasmin R, Desvergne B, et al. Selective cooperation between fatty acid binding proteins and the proliferator-activated receptors in regulating transcription. Mol Cell Biol 2002; 22:5114-5127 (Pubitemid 34700702)
46. Kelpe CL, Johnson LM, Poitout V. Increasing triglyceride synthesis inhibits glucose-induced insulin secretion in isolated rat islets of Langerhans. A study using adenoviral expression of diacylglycerol acyltransferase. Endocrinology 2002; 143:3326-3332
47. Moore PC, Ugas MA, Hagman DK, Parazzoli SD, Poitout V. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes 2004; 53:2610-2616 (Pubitemid 39299269)
48. Kelpe CL, Moore PC, Parazzoli SD, Wicksteed B, Rhodes CJ, Poitout V. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem 2003; 278:30015-30021 (Pubitemid 36962391)
49. Hagman DK, Hays LB, Parazzoli SD, Poitout V. Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J Biol Chem 2005; 280:32413-32418 (Pubitemid 41361852)
50. Solinas G, Naugler W, Galimi F, Lee M, Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrate. PNAS 2006; 103:16454-16459 (Pubitemid 44715217)
51. Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem 1996; 271:5633-5637 (Pubitemid 26083898)